Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Clinical trial NCT01155713 · COMPLETED
Trial details
- NCT number
- NCT01155713
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-11-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.